Recovery to baseline or =< grade  Common Terminology Criteria for Adverse Events (CTCAE) version (v).. from toxicities related to any prior treatments, unless adverse events (AEs) are clinically nonsignificant and/or stable on supportive therapy
Recovery from all prior surgical or adjuvant treatment-related toxicities, to baseline status, or a Common Terminology Criteria for Adverse Events (CTCAE) grade of  or , except for toxicities not considered a safety risk, such as alopecia; post-surgical pain will not be considered a basis for exclusion
Recovery to baseline or grade =<  Common Terminology Criteria for Adverse Events (CTCAE) version (v). from toxicities related to any prior treatments, unless adverse events (AEs) are clinically nonsignificant and/or stable on supportive therapy
Recovery to baseline or =< grade  CTCAE v.. from toxicities related to any prior treatments, unless adverse events (AEs) are clinically nonsignificant and/or stable on supportive therapy.
Subject has recovered from clinically significant acute treatment related toxicities from all prior therapies. Recovery is defined as a toxicity Grade ?  (common terminology criteria for adverse events [CTCAE] v. .).
The subject has recovery to baseline or =< grade  Common Terminology Criteria for Adverse Events (CTCAE) version (v.). from toxicities related to any prior treatments, unless adverse event (AE)(s) are clinically nonsignificant and/or stable on supportive therapy
Recovery to baseline or =< grade  Common Terminology Criteria for Adverse Events (CTCAE) version (v.). from toxicities related to any prior treatments, unless adverse events (AE[s]) are clinically non-significant and/or stable on supportive therapy
Recovery to baseline or =< grade  Common Terminology Criteria for Adverse Events (CTCAE) version . from toxicities related to any prior treatments, unless adverse events (AE[s]) are clinically non-significant and/or stable on supportive therapy
Recovery to baseline or =< grade  Common Terminology Criteria for Adverse Events (CTCAE) version . from toxicities related to any prior treatment, unless adverse events are clinically non-significant and/or stable on supportive therapy
Recovery from non-hematologic toxicities of salvage cytoreductive chemotherapy to =< grade  (Common Terminology Criteria for Adverse Events [CTCAE] version  [v])
Recovery from non-hematologic toxicities of salvage cytoreductive chemotherapy to =< grade  (Common Terminology Criteria for Adverse Events version  [CTCAE v])
RENAL COHORT: Recovery to baseline or ? grade  Common Terminology Criteria for Adverse Events (CTCAE) v.. from toxicities related to any prior treatments, unless adverse events (AEs) are clinically nonsignificant and/or stable on supportive therapy
Recovery to baseline or =< grade  Common Terminology Criteria for Adverse Events (CTCAE) version (v.). from toxicities related to any prior treatments, unless AE(s) are clinically non-significant and/or stable on supportive therapy
Patients must have recovered from clinically significant, acute, treatment-related toxicities of prior therapies; for those acute baseline adverse events attributable to prior therapy, recovery is defined as a toxicity grade =< , using Common Terminology Criteria for Adverse Events (CTCAE) version (v) ., unless otherwise specified in the inclusion and exclusion criteria\r\n* Agents that potentially fit into more than one category or do not clearly fit into any category listed above should be discussed with the study principal investigator (PI) prior to enrollment
Recovery to baseline or =< grade  Common Terminology Criteria for Adverse Events (CTCAE) version . from toxicities related to any prior treatment, unless adverse events are clinically non-significant and/or stable on supportive therapy
Subjects must have recovered from the acute toxicities of all prior therapy before entering this study; for those acute baseline adverse events attributable to prior therapy, recovery is defined as a toxicity grade =< , using Common Terminology Criteria for Adverse Events (CTCAE) version (v.) ., unless otherwise specified in the inclusion and exclusion criteria
Recovery to baseline or ? Grade  CTCAE v from toxicities related to any prior treatments, unless AE(s) are clinically nonsignificant and/or stable on supportive therapy.
Recovery to Grade  from all clinically significant adverse events related to prior MF therapy, including transplant-related toxicities.
Recovery to CTCAE (Common Terminology Criteria for Adverse Events Version .) Grade  or Grade  or recovery to baseline preceding the prior treatment of any previous drug / procedure-related toxicity (except alopecia, anemia, and hypothyroidism)
